Search
Clinical Practice Guidelines
EHA creates clinical practice Guidelines for diagnosis and treatment of hematologic diseases. This initiative started in 2019 with the establishment of the EHA Guidelines Committee and the definition of the EHA Methodology for Guidelines.
Read moreRegistration & accommodation
Register here
Individual RegistrationRegistration fee includes:
Access to the scientific and educational sessions of the meeting. Digital meeting materials including the program and abstract book. Networking opportunities during breaks, receptions and dinners.
Registration
Register here
Individual registrationHybrid registration includes:
In-person access to the scientific and educational sessions of the meeting
Meeting materials
Coffee/tea breaks on February 6-8, 2025 and lunches on February 7-8, 2025
Access to the Welcome Reception
Access to the Poster Session(s) and viewing of the physical…
EHA2025 delegate services [draft]
EHA is pleased to introduce delegate services for the upcoming EHA2025 Congress—services that registered participants can use prior, during, or after the event. Special airline fare
Enjoy a discounted flight rate and join us in Milan.
Abstract & Clinical Case Submission
Abstract submission is an important part of the 7th European CAR T-cell Meeting.
Read moreResearch
Research in hematology has dramatically improved our understanding of hematologic diseases and resulted in many innovative, groundbreaking discoveries.
Read moreMolecular Hematopoiesis Workshop
The Molecular Hematopoiesis Workshop at the EHA2025 Congress is back!
OrganizersChair: Michael Milsom (Germany)
Co-chairs: Kim De Keersmaecker (Belgium), Elisa Laurenti (United Kingdom) & Britta Will (United States)
Program The workshop will take place on Thursday, June 12, 2025 from 13:30 - 16:45…
EHA Mentorship Program
A new, career-focused program that provides individual mentoring support for early and mid-career clinicians and researchers in hematology. The call for mentees is open until 15:00 (CET) on February 20, 2025.
Read moreSelected EMA news
January 2025New medicines recommended for approval
Rytelo (imetelstat sodium) - orphan
Treatment of anemia (low levels of red blood cells)
Zefylti (filgrastim) – biosimilar
Treatment of neutropenia (low level of white blood cells) in patients having chemotherapy or a bone marrow transplant
New…